
The most downloaded content by health system pharmacy leaders in August 2025.
McKesson is here to help you navigate the biosimilar landscape
Date
July 25, 2023
Read time: 1 minute
By: McKesson Editorial Team
McKesson is here to help you navigate the biosimilar landscape and provide resources to physicians who are evaluating biosimilar drugs for their patients. Our advisors and resources can help you navigate every step of the biosimilar journey to help you achieve more.
Fill out the form to gain access to our Biosimilar Masterclass that includes videos with lessons from clinical experts, guidance on operational readiness, keys to a successful payor strategy, insights for biosimilar expansion across specialties, and trends emerging in the biosimilar market.
With available labor resources dwindling and a shrinking pipeline, health systems must find creative solutions for better using the personnel and partnerships they have.
At this year's event, our experts heard from health systems who may be underutilizing available tools and resources in 340B program management.
Click through this interactive experience for a closer look at what you can expect at this year’s HealthTrust University Conference.
Our experts continue shaping industry conversations through regular conference and event engagements, like the HealthTrust University 340B Summit.
A recent podcast includes first-hand insights on opportunities for collaboration in strengthening the supply chain to achieve more.
McKesson’s Head of Cell, Gene, and Advanced Therapies discusses opportunities and challenges with CGT in the health system.
This interactive experience highlights key aspects of our SPE solutions, designed to help your health system achieve more.
The first in a series of interviews with our Specialty Pharmacy Enablement expert, Ginger Thorpe, covering important questions health systems should be asking.